CREDIT SUISSE AG/ - FULCRUM THERAPEUTICS INC ownership

FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 90 filers reported holding FULCRUM THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of FULCRUM THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$148,376
-53.5%
52,062
+18.8%
0.00%
Q4 2022$319,010
+74.3%
43,820
+94.0%
0.00%
Q3 2022$183,000
+76.0%
22,590
+6.3%
0.00%
Q2 2022$104,000
-75.8%
21,261
+17.1%
0.00%
Q1 2022$429,000
+29.2%
18,156
-3.2%
0.00%
Q4 2021$332,00018,7520.00%
Other shareholders
FULCRUM THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
TRV GP III, LLC 3,962,202$70,091,00017.54%
TRV GP IV, LLC 2,343,154$41,450,00011.92%
ACUTA CAPITAL PARTNERS, LLC 200,000$3,538,0001.49%
HighVista Strategies LLC 89,963$1,591,0001.27%
Logos Global Management LP 685,000$12,118,0001.25%
Monashee Investment Management LLC 273,045$4,830,0001.19%
RTW INVESTMENTS, LP 3,866,872$68,405,0001.00%
Parkman Healthcare Partners LLC 250,106$4,424,0000.98%
Deep Track Capital, LP 750,000$13,268,0000.94%
Darwin Global Management, Ltd. 317,428$5,615,0000.86%
View complete list of FULCRUM THERAPEUTICS INC shareholders